Praveen Patel2017-10-12T12:22:21+01:00

PRAVEEN PATEL

Consultant Ophthalmologist | MA (Cantab), MB BChir (Cantab), FRCOphth, MD (Res)

AREAS OF EXPERTISE
ACCREDITATIONS
  • 1995 MA University of Cambridge (Pharmacology)
  • 1997 MB BChir University of Cambridge Medical School
  • 2006-2008 Clinical Research Fellowship at Moorfields Eye Hospital & UCL Institute of Ophthalmology
  • 2008 Medical Retina Fellowship at Moorfields Eye Hospital
  • 2009 FRCOphth Royal College of Ophthalmologists
  • 2011 MD (Res) University College London (UCL)
  • 2014 National Institute for Health Research (NIHR) North Thames Clinical Research Network Ophthalmology Research Specialty Lead

MEMBERSHIPS
  • Fellow of the Royal College of Ophthalmologists
  • Member of the Association into Research in Vision and Ophthalmology

  • International Member of the American Society of Retina Specialists

About Praveen Patel

Consultant Ophthalmologist | MA (Cantab), MB BChir (Cantab), FRCOphth, MD (Res)

Mr Praveen Patel studied medicine at Cambridge University. During his undergraduate degree, he really developed a passion for research. He studied ophthalmology at Moorfields Eye Hospital in London where he further developed his interest in clinical research. His passion and motivation as an ophthalmologist is providing cutting edge treatments for patients on the NHS and privately.

Training

Praveen Patel graduated from Cambridge University in 1997 with a first-class degree. He completed his post-graduate training in ophthalmology at Moorfields Eye Hospital, London.

Awards

As one of the lead investigators for the world’s first randomised trial of Avastin for age-related macular degeneration he won the Moorfields Research Medal for his work, published in the British Medical Journal.

Where Praveen Patel practices

Positions

Research and interests

Praveen is actively involved in research to find novel therapies for macular disease including age-related macular degeneration and offers access to latest treatments including Eylea, Lucentis and Jetrea injections for macular disease. His other key research interest areas are below.

More from Praveen Patel

We regularly share new videos and blog posts for our St Albans patients about your consultant and common eye questions and concerns.

Vision loss after 40: A VisionSafe Eye Check might catch signs of AMD, glaucoma, macular or retinal conditions.

September 26th, 2019|

Vision loss after the age of 40 is common, and there are several reasons this happens. One of the most prevalent reasons is an age-related change in our focusing which means we are not able to read small print easily without glasses (also known as presbyopia). However, there are more serious eye conditions which can lead to irreversible vision loss if not detected at an early stage.

What is macular degeneration?

September 19th, 2019|

AMD is a condition which affects the retina, the light-sensitive membrane at the back of the eye. As we get older, we develop an accumulation of waste material underneath the retina. This accumulation can affect the function of the light-sensitive cells.

VIEW ALL ARTICLES

Memberships and affiliations

Our Consultant Ophthalmologists love to stay on top of the latest in eye treatment options for patients through regular industry meetings, journals and research.

Request a Call Back

Whether you’d like to book a VisionSafe Eye Check, or discover your eye treatment options, give us a call on: 01727 227 013 or request a call back below: